Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Sharp Therapeutics logo — Developing small molecule drugs for genetic diseases..

Sharp Therapeutics

Developing small molecule drugs for genetic diseases..

Founded 2010 United States Pittsburgh, United States 10 employees Biopharma, Biotechnology +1

General Information

Company Name Sharp Therapeutics
Founded Year 2010
Location United States Pittsburgh, United States
Employees 10
Industries Biopharma, Biotechnology, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with Sharp Therapeutics. To contact Sharp Therapeutics, visit sharptx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sharp Therapeutics compare?

A PDF of Sharp Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sharp Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sharp Therapeutics

Sharp Edge Labs is a preclinical-stage life sciences company focused on developing small molecule drugs for genetic diseases. The company's approach involves targeting monogenic diseases to de-risk the clinical path, with each pipeline program catering to a genetically identifiable subset of patients and boasting an early Phase IB pharmacodynamic readout. Sharp Edge Labs employs three core technologies, including CoreX™, AlloChem™, and Disco/Mine™, to establish a scalable platform for discovery and development. With over 10 programs at various stages of development, the company's pipeline covers areas such as Frontotemporal Dementia, genetic subsets of Alzheimer’s and Parkinson’s, as well as lysosomal storage disorders and other loss-of-function diseases. The team and advisors at Sharp Edge Labs comprise former and current executives from prominent pharmaceutical and biotech companies, such as Genzyme/Sanofi, Synageva, Pfizer, and Shire. Founded in 2010 and headquartered in the United States, the company is at the forefront of revolutionizing treatment for genetic diseases through its innovative small molecule drug development approach.

Business keywords: small molecule drugs, genetic diseases, preclinical-stage, monogenic disease, pharmacodynamic readout, cellular models, compound library, computational biology, Frontotemporal Dementia, Alzheimer’s, Parkinson’s, lysosomal storage disorders, drug discovery, life sciences

No funding data available for Sharp Therapeutics yet.

Sharp Therapeutics Alternatives & Competitors

View All Alternatives
Sharp Therapeutics vs
Muna Therapeutics
Muna Therapeutics Denmark

Discovering and developing transformative therapeutics for neurodegenerative diseases

Grant
54 employees
Biopharma, Biotechnology
Compare Sharp Therapeutics vs Muna Therapeutics
Sharp Therapeutics vs
SyntheticGestalt
SyntheticGestalt Japan

Scientific Research by Artificially Intelligent Agents

20 employees
Biotechnology, Pharmaceutical
Sharp Therapeutics vs
Alivexis, Inc
Alivexis, Inc Japan

Delivering the future of medicines

Series C
12 employees
Biotechnology, Pharmaceutical
View all alternatives

FAQ About Sharp Therapeutics

Developing small molecule drugs for genetic diseases..
Sharp Therapeutics was founded in 2010.
Sharp Therapeutics is headquartered in Pittsburgh, United States.
Sharp Therapeutics operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on small molecule drugs, genetic diseases, preclinical-stage and monogenic disease.
Sharp Therapeutics has approximately 10 employees.
Top alternatives and competitors to Sharp Therapeutics include Muna Therapeutics, SyntheticGestalt, Alivexis, Inc, Cantabio Pharmaceuticals, Inc., Gain Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sharp Therapeutics and Muna Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sharp Therapeutics, https://bouncewatch.com/company/sharp-edge-labs-1, updated 6 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes